Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s12885-018-5215-7
DC Field | Value | |
---|---|---|
dc.title | Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018) | |
dc.contributor.author | Tan, Wan-Ling | |
dc.contributor.author | Ng, Quan Sing | |
dc.contributor.author | Lim, Cindy | |
dc.contributor.author | Tan, Eng Huat | |
dc.contributor.author | Toh, Chee Keong | |
dc.contributor.author | Ang, Mei-Kim | |
dc.contributor.author | Kanesvaran, Ravindran | |
dc.contributor.author | Jain, Amit | |
dc.contributor.author | Tan, Daniel SW | |
dc.contributor.author | Lim, Darren Wan-Teck | |
dc.date.accessioned | 2022-04-07T08:10:35Z | |
dc.date.available | 2022-04-07T08:10:35Z | |
dc.date.issued | 2018-12-24 | |
dc.identifier.citation | Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel SW, Lim, Darren Wan-Teck (2018-12-24). Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018). BMC CANCER 18 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-018-5215-7 | |
dc.identifier.issn | 14712407 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/218599 | |
dc.description.abstract | Following publication of the original article [1], the authors notified us of a typographical error in Table 1. The corrected Table 1 is presented below. (Table Presented). | |
dc.language.iso | en | |
dc.publisher | BMC | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Oncology | |
dc.type | Article | |
dc.date.updated | 2022-04-07T02:38:27Z | |
dc.contributor.department | DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.contributor.department | DUKE-NUS OFFICE OF ACAD & CLINICAL DEVT | |
dc.description.doi | 10.1186/s12885-018-5215-7 | |
dc.description.sourcetitle | BMC CANCER | |
dc.description.volume | 18 | |
dc.description.issue | 1 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Correction to Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.pdf | 235.92 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.